Inhibition of cell proliferation, migration and invasion of B16-F10 melanoma cells by α-mangostin

被引:29
作者
Beninati, Simone [1 ]
Oliverio, Serafina [1 ]
Cordella, Martina [2 ]
Rossi, Stefania [3 ]
Senatore, Cinzia [3 ]
Liguori, Immacolata [1 ]
Lentini, Alessandro [1 ]
Piredda, Lucia [1 ]
Tabolacci, Claudio [1 ,2 ]
机构
[1] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy
[2] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy
[3] Regina Elena Inst Canc Res, Rome, Italy
关键词
alpha-Mangostin; Melanoma; Antimetastatic effects; Natural drugs; GARCINIA-MANGOSTANA; SKIN-CANCER; IN-VITRO; XANTHONES; APOPTOSIS; PERICARP;
D O I
10.1016/j.bbrc.2014.07.031
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we have evaluated the potential antineoplastic effects of alpha-mangostin (alpha-M), the most representative xanthone in Garcinia mangostana pericarp, on melanoma cell lines. This xanthone markedly inhibits the proliferation of high-metastatic B16-F10 melanoma cells. Furthermore, by deeply analyzing which steps in the metastatic process are influenced by xanthone it was observed that alpha-M strongly interferes with homotypic aggregation, adhesion, plasticity and invasion ability of B16-F10 cells, probably by the observed reduction of metalloproteinase-9 activity. The antiproliferative and antimetastatic properties of alpha-M have been established in human SK-MEL-28 and A375 melanoma cells. In order to identify pathways potentially involved in the antineoplastic properties of alpha-M, a comparative mass spectrometry proteomic approach was employed. These findings may improve our understanding of the molecular mechanisms underlying the anti-cancer effects of alpha-M on melanoma. (C) 2014 Published by Elsevier Inc.
引用
收藏
页码:1512 / 1517
页数:6
相关论文
共 36 条
[1]   A novel RGDS-analog inhibits angiogenesis in vitro and in vivo [J].
Aguzzi, MS ;
Facchiano, F ;
Ribatti, D ;
Gaeta, R ;
Casadio, R ;
Rossi, I ;
Capogrossi, MC ;
Facchiano, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (04) :809-814
[2]   Tissue transglutaminase-induced down-regulation of matrix metalloproteinase-9 [J].
Ahn, Jun-Seok ;
Kim, Min-kyung ;
Hahn, Jang-hee ;
Park, Jung-Hyeun ;
Park, Kyeong-Han ;
Cho, Byung-Ryul ;
Park, Seung-Bae ;
Kim, Dae-joong .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 376 (04) :743-747
[3]   The transglutaminase family: an overview: Minireview article [J].
Beninati, S ;
Piacentini, M .
AMINO ACIDS, 2004, 26 (04) :367-372
[4]   Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma [J].
Bialy, TL ;
Rothe, MJ ;
Grant-Kels, JM .
DERMATOLOGIC SURGERY, 2002, 28 (12) :1143-1152
[5]   Apoptosis in physiological and pathological skin: Implications for therapy [J].
Boehm, Ingrid .
CURRENT MOLECULAR MEDICINE, 2006, 6 (04) :375-394
[6]   Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation [J].
Busca, R ;
Bertolotto, C ;
Ortonne, JP ;
Ballotti, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (50) :31824-31830
[7]   Evidence that the small GTPase Rab8 is involved in melanosome traffic and dendrite extension in B16 melanoma cells [J].
Chakraborty, AK ;
Funasaka, Y ;
Araki, K ;
Horikawa, T ;
Ichihashi, M .
CELL AND TISSUE RESEARCH, 2003, 314 (03) :381-388
[8]   Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma [J].
Cho, NH ;
Shim, HS ;
Rha, SY ;
Kang, SH ;
Hong, SH ;
Choi, YD ;
Hong, SJ ;
Cho, SH .
EUROPEAN UROLOGY, 2003, 44 (05) :560-566
[9]  
Dela Cruz F, 2012, ONCOTARGET, V3, P559
[10]   Current management of melanoma [J].
Dunki-Jacobs, Erik M. ;
Callendar, Glenda G. ;
McMasters, Kelly M. .
CURRENT PROBLEMS IN SURGERY, 2013, 50 (08) :351-382